Life Insurance with Atrial Fibrillation | AFib

Atrial fibrillation (AFib) is one of the most common cardiac conditions underwriters encounter — and also one of the most variable in terms of outcome. A 45-year-old with lone paroxysmal AFib well-controlled on medication may qualify for standard rates at select carriers, while someone with persistent AFib, a history of stroke, or significant structural heart disease may face table ratings or decline. The type of AFib, ventricular rate control, anticoagulation compliance, and presence of co-morbid conditions are the four variables that drive everything.

What Underwriters Evaluate for Atrial Fibrillation

Every AFib case is reviewed individually. These are the factors that determine whether you qualify, at what rating, and with which carrier:

AFib Type (Paroxysmal, Persistent, or Permanent) — Paroxysmal AFib (episodes that self-terminate) is viewed most favorably, especially when infrequent and well-controlled. Persistent AFib (requires intervention to restore rhythm) carries moderate risk. Permanent AFib (ongoing, rhythm restoration no longer pursued) is the most restrictive category and typically results in table ratings rather than standard offers.

Ventricular Rate Control — Carriers want to see a well-controlled resting heart rate, typically below 80–90 bpm. Poorly controlled ventricular rate suggests inadequate treatment or non-compliance, both of which increase perceived mortality risk.

Anticoagulation Therapy — Most AFib patients are prescribed anticoagulants (warfarin, apixaban, rivaroxaban, etc.) to reduce stroke risk. Compliance is viewed positively. Refusal or inconsistent use raises concern about stroke and bleeding risk management.

Time Since Diagnosis and Stability — A recent diagnosis (within the past 6–12 months) typically triggers a waiting period at most carriers until stability is established. Longer history with documented stable control is viewed more favorably.

Underlying Structural Heart Disease — Lone AFib (no underlying structural cause) is the most favorable presentation. AFib secondary to coronary artery disease, cardiomyopathy, heart failure, or valvular disease compounds risk significantly and is underwritten as part of the broader cardiac profile.

Stroke or TIA History — Any prior stroke or transient ischemic attack (TIA) attributed to AFib significantly worsens the underwriting outcome and is evaluated as a separate cardiac/neurological risk factor on top of the AFib itself.

CHADS2 / CHA₂DS₂-VASc Score — Some carriers reference stroke risk scoring tools. Higher scores (driven by age, hypertension, diabetes, heart failure history, or prior stroke) signal greater risk and result in higher table ratings.

AFib Type and Severity: General Underwriting Outlook

Below is a general guide to how carriers approach AFib based on type and clinical presentation. Individual cases vary significantly based on co-morbidities and full medical history.

AFib Profile	Typical Rating Range	Best Achievable Rating	Notes
Lone paroxysmal, well-controlled, age under 50	Standard to Table 2	Standard at select carriers	Most favorable; stable 12+ months required
Lone paroxysmal, well-controlled, age 50–65	Table 2–4	Table 2	Age increases stroke risk perception
Paroxysmal with hypertension or controlled diabetes	Table 2–6	Table 2–4	Each co-morbidity adds independent rating
Persistent, rate-controlled, no structural disease	Table 4–6	Table 4	Anticoagulation compliance critical
Permanent, well-managed	Table 4–8	Table 4–6	Depends heavily on overall cardiac health
AFib with prior stroke or TIA	Table 6–10 or decline	Table 6–8 (stroke 3+ yrs ago)	Two risk factors evaluated independently
AFib with structural heart disease	Table 8–10 or decline	Decline at most carriers	Guaranteed issue may be only option
Recent diagnosis under 6 months, unstabilized	Postponement	Postponement	6–12 months stable control required first

Guidelines current as of 2025–2026. Carrier underwriting guidelines are subject to change. Verify with us before applying.

Carrier Guidelines: AFib Underwriting Comparison

Carriers vary meaningfully in how they approach AFib. The difference between the most and least competitive carrier for the same applicant can be 2–4 table ratings.

Carrier	Paroxysmal AFib	Persistent / Permanent	Notes
Protective Life	Standard possible, lone paroxysmal age under 55	Table 4–6 persistent	One of the most competitive for well-controlled lone AFib
Banner / Legal & General	Table 2 typical; standard case-by-case	Table 4–6 with good rate control	Competitive term pricing; strong for younger applicants
Prudential	Standard to Table 2 with 12+ months stability	Table 4–6; medical director review available	Flexible on lone AFib; borderline cases benefit from review
Pacific Life	Table 2 typical	Table 4–6; permanent evaluated individually	Strong for applicants with clean echocardiograms
Transamerica	Table 2–4; more conservative	Table 6+; limited appetite for permanent	Better for straightforward profiles with no co-morbidities
North American	Table 2–4	Table 4–8 persistent	Solid mid-tier option; less competitive for best cases
Lincoln Financial	Table 2 with complete cardiology records	Table 4–6 persistent	Requires echocardiogram; strong on well-documented cases
Mutual of Omaha	Table 2–4; requires cardiology follow-up	Table 6+; simplified issue available	Good fallback for cases that do not qualify fully underwritten

Guidelines current as of 2025–2026. Carrier underwriting guidelines are subject to change. Verify with us before applying.

Situations That Typically Result in Decline or Postponement

Recent Diagnosis or Unstabilized AFib (under 6 months) — Most fully underwritten carriers require a minimum of 6–12 months of documented rate control and stable treatment before they will consider an application. A diagnosis within the past 6 months typically triggers a postponement rather than an outright decline — once stability is established, coverage becomes available.

AFib with Structural Heart Disease — When AFib is secondary to coronary artery disease, cardiomyopathy, or congestive heart failure, the underlying structural condition dominates the underwriting outcome. Most standard carriers will decline; graded benefit or guaranteed issue products may be the most viable path.

AFib with Prior Stroke or TIA — Combined stroke and AFib history results in decline at most standard carriers except where the stroke was several years ago with full neurological recovery. Even then, options are limited and table ratings are high.

Uncontrolled Ventricular Rate or Non-Compliance — Applicants with documented uncontrolled heart rates, missed cardiology appointments, or inconsistent anticoagulation compliance will face decline or very high ratings. Carriers interpret non-compliance as both a direct medical risk and an indicator of overall health management habits.

What You Can Do to Improve Your Outcome

Maintain current cardiology records. Carriers will request echocardiogram results, Holter monitor findings, electrophysiology notes, and documentation of rate or rhythm control. Having these records organized and current before applying significantly reduces delays and demonstrates active management of the condition.

Establish a documented treatment history. A 12+ month track record of stable rate control, consistent medication compliance, and regular cardiology follow-up is the single biggest lever for improving your rating. Applying too soon after diagnosis creates a record that can affect future applications.

Disclose anticoagulation status accurately. Anticoagulation therapy is viewed as positive evidence of proper stroke-risk management. Disclosing it fully, including the specific medication, dosage, and most recent INR values if on warfarin, helps underwriters assess the case properly rather than filling gaps with conservative assumptions.

Work with a specialist broker who understands cardiac underwriting. The difference between the most and least competitive carrier for an AFib applicant is often 2–4 table ratings — a cost difference that can add thousands of dollars per year in premiums. Applying directly to a single carrier without shopping the case informally first means accepting an offer that may be far from the market best.

AFib History? Let’s Find the Right Carrier.

AFib underwriting is highly carrier-specific — the same applicant can receive a standard rate at one carrier and a Table 4 at another. We know which carriers are most competitive for which AFib profiles and will identify your best option before any formal application is submitted.

Call 1-888-972-0024

Browse All High-Risk Conditions

Understanding Your Rating: Life Insurance Risk Classifications | Table Ratings Explained (B–J) | Flat Extra Ratings

Authoritative Resources: Life insurance underwriting practices are regulated by the NAIC. Insurers may check your health history through the MIB Group — you can request your free annual MIB report at mib.com.

Frequently Asked Questions

Can I get life insurance with atrial fibrillation?

Yes. Atrial fibrillation is insurable in many cases. Outcomes depend heavily on the type of AFib (paroxysmal, persistent, or permanent), how well your ventricular rate is controlled, whether you are on anticoagulation therapy, and the absence of underlying structural heart disease. Well-controlled paroxysmal AFib with no co-morbidities can qualify for standard rates at select carriers.

What is the best rate class I can get with AFib?

The best achievable rate class depends on your AFib profile. Lone paroxysmal AFib in a younger applicant with excellent rate control, compliance with anticoagulation, and no co-morbidities can qualify for standard rates at select carriers such as Protective Life or Prudential. Most AFib applicants receive table-rated offers ranging from Table 2 to Table 6 depending on the severity and clinical picture.

Does AFib automatically disqualify me from life insurance?

No. Atrial fibrillation is not an automatic decline. Many applicants with well-controlled AFib obtain coverage at table ratings. The most significant factors that result in decline are AFib combined with structural heart disease, a prior stroke, or persistent AFib with poor rate control. For straightforward paroxysmal AFib with no complications, multiple carriers will make an offer.

How does anticoagulation therapy affect my life insurance application?

Anticoagulation therapy — warfarin, apixaban, rivaroxaban, or similar medications — is generally viewed positively by underwriters. It demonstrates active stroke-risk management. Disclosing it fully, including the specific medication and most recent INR values if on warfarin, helps underwriters assess the case accurately rather than making conservative assumptions.

How long after an AFib diagnosis should I wait before applying for life insurance?

Most carriers require a minimum of 6 to 12 months of documented stable rate or rhythm control before they will consider an AFib applicant. Applying too soon after a new diagnosis, medication change, or cardioversion procedure typically results in postponement. Waiting for a documented period of stability significantly improves both the likelihood of approval and the rate offered.

Life Insurance with Atrial Fibrillation | AFib Life Insurance | High Risk